Average Co-Inventor Count = 5.80
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neurotech Pharmaceuticals Co., Ltd. (4 from 8 patents)
2. Neurotech Co., Ltd. (3 from 5 patents)
3. Pharmabcine Inc. (2 from 10 patents)
4. Amkor Pharma, Inc. (1 from 3 patents)
10 patents:
1. 10155817 - Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same
2. 9963512 - Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same
3. 8686185 - Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts
4. 8211877 - Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
5. 8211878 - Method for reducing neuronal death in nervous system injuries resulting from amyotrophic lateral sclerosis
6. 7750045 - Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
7. 7319160 - Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
8. 6964982 - Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
9. 6573402 - Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
10. 6521640 - Method for interviewing neuronal death using sulfasalazine